TNFAIP8 and Familial prostate cancer: We also showed that TNFAIP8 increased resistance to the anticancer drugs, docetaxel, and doxorubicin, and promoted cell proliferation and cell growth in prostate cancer cells through the inactivation of cellular apoptosis and the induction of cellular autophagy.